Please assess the completion status of the following clinical trial:

Trial Title: Hyaluronic Acid in Acute Exacerbation of COPD - Duration Of Noninvasive Assistance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 18 years of age or older~* Admitted for respiratory failure primarily due to COPD exacerbation~* Requiring non-invasive ventilation~* Respiratory distress, as evidenced by moderate-to-severe dyspnea and use of accessory muscles of respiration~* Hypercapnic respiratory failure~* High respiratory rate~Exclusion Criteria:~* Respiratory arrest or the need for immediate intubation~* Upper airways obstruction~* Facial trauma~* Inability to cooperate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- HMW-HA (Type: EXPERIMENTAL): HMW-HA (Yabro - 5 ml of saline containing 0.3% hyaluronic acid sodium salt) via nebulizer b.i.d.
- Placebo (Type: PLACEBO_COMPARATOR): 5 ml of saline via nebulizer b.i.d.

Based on this trial design, predict the completion outcome and termination type (if applicable).